Pacific Biosciences of California, Inc. Research and Development Expense
Pacific Biosciences of California, Inc. (PACB) reported Research and Development Expense of $23.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- Pacific Biosciences of California, Inc. research and development expense for the quarter ending 2026-06-30 was $23.02M, a 2.19% increase year-over-year.
- Pacific Biosciences of California, Inc. research and development expense for the quarter ending 2026-03-31 was $19.61M, a 32.51% decline year-over-year.
- Pacific Biosciences of California, Inc. research and development expense for the quarter ending 2025-12-31 was $22.88M, a 16.70% decline year-over-year.
- Pacific Biosciences of California, Inc. research and development expense for the quarter ending 2025-09-30 was $22.85M, a 10.46% decline year-over-year.
- Pacific Biosciences of California, Inc. research and development expense for fiscal 2025 was $97.31M, a 27.88% decline from fiscal 2024.
- Pacific Biosciences of California, Inc. research and development expense for fiscal 2024 was $134.92M, a 27.91% decline from fiscal 2023.
- Pacific Biosciences of California, Inc. research and development expense for fiscal 2023 was $187.17M, a 3.02% decline from fiscal 2022.
- Pacific Biosciences of California, Inc. research and development expense for fiscal 2022 was $193.00M, a 70.95% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $23.02M 10-Q · filed 2026-08-06 | $42.63M 10-Q · filed 2026-08-06 | $65.51M derived: sum of 3 quarters · filed 2026-08-06 | $88.36M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $19.61M 10-Q · filed 2026-05-08 | $42.49M derived: sum of 2 quarters · filed 2026-05-08 | $65.33M derived: sum of 3 quarters · filed 2026-05-08 | $87.86M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $22.88M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $45.73M derived: sum of 2 quarters · filed 2026-02-25 | $68.25M derived: sum of 3 quarters · filed 2026-08-06 | $97.31M 10-K · filed 2026-02-25 |
| 2025-09-30 | $22.85M 10-Q · filed 2025-11-06 | $45.38M derived: sum of 2 quarters · filed 2026-08-06 | $74.43M 10-Q · filed 2025-11-06 | $101.89M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $22.53M 10-Q · filed 2026-08-06 | $51.58M 10-Q · filed 2026-08-06 | $79.05M derived: sum of 3 quarters · filed 2026-08-06 | $104.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $29.05M 10-Q · filed 2026-05-08 | $56.52M derived: sum of 2 quarters · filed 2026-05-08 | $82.03M derived: sum of 3 quarters · filed 2026-05-08 | $120.52M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $27.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $52.98M derived: sum of 2 quarters · filed 2026-02-25 | $91.47M derived: sum of 3 quarters · filed 2026-02-25 | $134.92M 10-K · filed 2026-02-25 |
| 2024-09-30 | $25.52M 10-Q · filed 2025-11-06 | $64.00M derived: sum of 2 quarters · filed 2025-11-06 | $107.46M 10-Q · filed 2025-11-06 | $152.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $38.48M 10-Q · filed 2025-08-07 | $81.94M 10-Q · filed 2025-08-07 | $126.48M derived: sum of 3 quarters · filed 2026-02-25 | $174.00M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $43.45M 10-Q · filed 2025-05-12 | $88.00M derived: sum of 2 quarters · filed 2026-02-25 | $135.51M derived: sum of 3 quarters · filed 2026-02-25 | $181.69M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $44.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $92.06M derived: sum of 2 quarters · filed 2026-02-25 | $138.23M derived: sum of 3 quarters · filed 2026-02-25 | $187.17M 10-K · filed 2026-02-25 |
| 2023-09-30 | $47.51M 10-Q · filed 2024-11-12 | $93.69M derived: sum of 2 quarters · filed 2024-11-12 | $142.63M 10-Q · filed 2024-11-12 | $185.25M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | $46.17M 10-Q · filed 2024-08-09 | $95.11M 10-Q · filed 2024-08-09 | $137.74M derived: sum of 3 quarters · filed 2025-03-17 | $184.83M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | $48.94M 10-Q · filed 2024-05-09 | $91.56M derived: sum of 2 quarters · filed 2025-03-17 | $138.65M derived: sum of 3 quarters · filed 2025-03-17 | $189.00M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | $42.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $89.72M derived: sum of 2 quarters · filed 2025-03-17 | $140.06M derived: sum of 3 quarters · filed 2025-03-17 | $193.00M 10-K · filed 2025-03-17 |
| 2022-09-30 | $47.09M 10-Q · filed 2023-11-03 | $97.44M derived: sum of 2 quarters · filed 2023-11-03 | $150.38M 10-Q · filed 2023-11-03 | $192.95M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $50.35M 10-Q · filed 2023-08-04 | $103.28M 10-Q · filed 2023-08-04 | $145.86M derived: sum of 3 quarters · filed 2024-02-28 | $173.37M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $52.94M 10-Q · filed 2023-05-04 | $95.51M derived: sum of 2 quarters · filed 2024-02-28 | $123.02M derived: sum of 3 quarters · filed 2024-02-28 | $145.29M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $42.58M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $70.08M derived: sum of 2 quarters · filed 2024-02-28 | $92.35M derived: sum of 3 quarters · filed 2024-02-28 | $112.90M 10-K · filed 2024-02-28 |
| 2021-09-30 | $27.51M 10-Q · filed 2022-11-08 | $49.77M derived: sum of 2 quarters · filed 2022-11-08 | $70.32M 10-Q · filed 2022-11-08 | $87.75M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $22.27M 10-Q · filed 2022-08-08 | $42.81M 10-Q · filed 2022-08-08 | $60.24M derived: sum of 3 quarters · filed 2023-02-28 | $76.71M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $20.55M 10-Q · filed 2022-05-06 | $37.97M derived: sum of 2 quarters · filed 2023-02-28 | $54.44M derived: sum of 3 quarters · filed 2023-02-28 | $69.45M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $17.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $33.89M derived: sum of 2 quarters · filed 2023-02-28 | $48.90M derived: sum of 3 quarters · filed 2023-02-28 | $64.15M 10-K · filed 2023-02-28 |
| 2020-09-30 | $16.47M 10-Q · filed 2021-11-05 | $31.48M derived: sum of 2 quarters · filed 2021-11-05 | $46.73M 10-Q · filed 2021-11-05 | $61.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $15.01M 10-Q · filed 2021-08-06 | $30.26M 10-Q · filed 2021-08-06 | $44.53M derived: sum of 3 quarters · filed 2022-02-28 | $59.49M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $15.25M 10-Q · filed 2021-05-06 | $29.52M derived: sum of 2 quarters · filed 2022-02-28 | $44.48M derived: sum of 3 quarters · filed 2022-02-28 | $59.40M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | $14.27M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $29.23M derived: sum of 2 quarters · filed 2022-02-28 | $44.15M derived: sum of 3 quarters · filed 2022-02-28 | $59.63M 10-K · filed 2022-02-28 |
| 2019-09-30 | $14.96M 10-Q · filed 2020-11-03 | $29.87M derived: sum of 2 quarters · filed 2020-11-03 | $45.36M 10-Q · filed 2020-11-03 | $61.62M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $14.91M 10-Q · filed 2020-08-06 | $30.39M 10-Q · filed 2020-08-06 | $46.66M derived: sum of 3 quarters · filed 2021-02-26 | $61.01M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $15.48M 10-Q · filed 2020-05-08 | $31.75M derived: sum of 2 quarters · filed 2021-02-26 | $46.10M derived: sum of 3 quarters · filed 2021-02-26 | $61.77M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $16.26M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $30.62M derived: sum of 2 quarters · filed 2021-02-26 | $46.28M derived: sum of 3 quarters · filed 2021-02-26 | $62.59M 10-K · filed 2021-02-26 |
| 2018-09-30 | $14.36M 10-Q · filed 2019-11-07 | $30.02M derived: sum of 2 quarters · filed 2019-11-07 | $46.33M 10-Q · filed 2019-11-07 | $61.96M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $15.66M 10-Q · filed 2019-08-06 | $31.98M 10-Q · filed 2019-08-06 | $47.60M derived: sum of 3 quarters · filed 2020-02-28 | $63.45M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $16.31M 10-Q · filed 2019-05-03 | $31.94M derived: sum of 2 quarters · filed 2020-02-28 | $47.78M derived: sum of 3 quarters · filed 2020-02-28 | $64.66M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $15.63M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $31.47M derived: sum of 2 quarters · filed 2020-02-28 | $48.35M derived: sum of 3 quarters · filed 2020-02-28 | $65.32M 10-K · filed 2020-02-28 |
| 2017-09-30 | $15.84M 10-Q · filed 2018-11-05 | $32.73M derived: sum of 2 quarters · filed 2018-11-05 | $49.70M 10-Q · filed 2018-11-05 | $65.95M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $16.88M 10-Q · filed 2018-08-03 | $33.85M 10-Q · filed 2018-08-03 | $50.11M derived: sum of 3 quarters · filed 2019-02-26 | $67.59M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $16.97M 10-Q · filed 2018-05-02 | $33.23M derived: sum of 2 quarters · filed 2019-02-26 | $50.70M derived: sum of 3 quarters · filed 2019-02-26 | $68.23M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $16.25M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $33.73M derived: sum of 2 quarters · filed 2019-02-26 | $51.26M derived: sum of 3 quarters · filed 2019-02-26 | $67.62M 10-K · filed 2019-02-26 |
| 2016-09-30 | $17.48M 10-Q · filed 2017-11-02 | $35.00M derived: sum of 2 quarters · filed 2017-11-02 | $51.36M 10-Q · filed 2017-11-02 | $66.11M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $17.52M 10-Q · filed 2017-08-02 | $33.88M 10-Q · filed 2017-08-02 | $48.63M derived: sum of 3 quarters · filed 2018-02-26 | $64.80M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $16.36M 10-Q · filed 2017-05-05 | $31.11M derived: sum of 2 quarters · filed 2018-02-26 | $47.27M derived: sum of 3 quarters · filed 2018-02-26 | $62.32M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $14.75M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $30.91M derived: sum of 2 quarters · filed 2018-02-26 | $45.96M derived: sum of 3 quarters · filed 2018-02-26 | $60.44M 10-K · filed 2018-02-26 |
| 2015-09-30 | $16.16M 10-Q · filed 2016-11-04 | $31.20M derived: sum of 2 quarters · filed 2016-11-04 | $45.69M 10-Q · filed 2016-11-04 | $58.02M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-06-30 | $15.04M 10-Q · filed 2016-08-04 | $29.53M 10-Q · filed 2016-08-04 | $41.86M derived: sum of 3 quarters · filed 2017-03-06 | $53.55M derived: sum of 4 quarters · filed 2017-03-06 |
| 2015-03-31 | $14.48M 10-Q · filed 2016-05-05 | $26.81M derived: sum of 2 quarters · filed 2017-03-06 | $38.51M derived: sum of 3 quarters · filed 2017-03-06 | $50.94M derived: sum of 4 quarters · filed 2017-03-06 |
| 2014-12-31 | $12.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $24.02M derived: sum of 2 quarters · filed 2017-03-06 | $36.46M derived: sum of 3 quarters · filed 2017-03-06 | $48.23M 10-K · filed 2017-03-06 |
| 2014-09-30 | $11.69M 10-Q · filed 2015-11-05 | $24.13M derived: sum of 2 quarters · filed 2015-11-05 | $35.90M 10-Q · filed 2015-11-05 | $47.03M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-06-30 | $12.44M 10-Q · filed 2015-08-05 | $24.21M 10-Q · filed 2015-08-05 | $35.34M derived: sum of 3 quarters · filed 2016-03-11 | $45.76M derived: sum of 4 quarters · filed 2016-03-11 |
| 2014-03-31 | $11.77M 10-Q · filed 2015-05-05 | $22.90M derived: sum of 2 quarters · filed 2016-03-11 | $33.32M derived: sum of 3 quarters · filed 2016-03-11 | $45.01M derived: sum of 4 quarters · filed 2016-03-11 |
| 2013-12-31 | $11.13M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $21.55M derived: sum of 2 quarters · filed 2016-03-11 | $33.23M derived: sum of 3 quarters · filed 2016-03-11 | $45.22M 10-K · filed 2016-03-11 |
| 2013-09-30 | $10.42M 10-Q · filed 2014-11-05 | $22.10M derived: sum of 2 quarters · filed 2014-11-05 | $34.08M 10-Q · filed 2014-11-05 | $45.74M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | $11.68M 10-Q · filed 2014-08-05 | $23.66M 10-Q · filed 2014-08-05 | $35.32M derived: sum of 3 quarters · filed 2015-03-12 | $47.94M derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $11.98M 10-Q · filed 2014-05-08 | $23.64M derived: sum of 2 quarters · filed 2015-03-12 | $36.26M derived: sum of 3 quarters · filed 2015-03-12 | $47.53M derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | $11.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $24.28M derived: sum of 2 quarters · filed 2015-03-12 | $35.55M derived: sum of 3 quarters · filed 2015-03-12 | $47.62M 10-K · filed 2015-03-12 |
| 2012-09-30 | $12.63M 10-Q · filed 2013-11-12 | $23.90M derived: sum of 2 quarters · filed 2013-11-12 | $35.97M 10-Q · filed 2013-11-12 | $48.39M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-06-30 | $11.27M 10-Q · filed 2013-08-09 | $23.34M 10-Q · filed 2013-08-09 | $35.76M derived: sum of 3 quarters · filed 2014-03-14 | $55.76M derived: sum of 4 quarters · filed 2014-03-14 |
| 2012-03-31 | $12.07M 10-Q · filed 2013-05-10 | $24.49M derived: sum of 2 quarters · filed 2014-03-14 | $44.49M derived: sum of 3 quarters · filed 2014-03-14 | $64.03M derived: sum of 4 quarters · filed 2014-03-14 |
| 2011-12-31 | $12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | $32.42M derived: sum of 2 quarters · filed 2014-03-14 | $51.96M derived: sum of 3 quarters · filed 2014-03-14 | $76.08M 10-K · filed 2014-03-14 |
| 2011-09-30 | $20.00M 10-Q · filed 2012-11-01 | $39.55M derived: sum of 2 quarters · filed 2012-11-01 | $63.66M 10-Q · filed 2012-11-01 | $90.21M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-06-30 | $19.55M 10-Q · filed 2012-08-07 | $43.66M 10-Q · filed 2012-08-07 | $70.21M derived: sum of 3 quarters · filed 2013-03-15 | $103.08M derived: sum of 4 quarters · filed 2013-03-15 |
| 2011-03-31 | $24.12M 10-Q · filed 2012-05-07 | $50.66M derived: sum of 2 quarters · filed 2013-03-15 | $83.53M derived: sum of 3 quarters · filed 2013-03-15 | $110.61M derived: sum of 4 quarters · filed 2013-03-15 |
| 2010-12-31 | $26.54M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-15 | $59.41M derived: sum of 2 quarters · filed 2013-03-15 | $86.50M derived: sum of 3 quarters · filed 2013-03-15 | $111.82M 10-K · filed 2013-03-15 |
| 2010-09-30 | $32.87M 10-Q · filed 2011-11-14 | $59.95M derived: sum of 2 quarters · filed 2011-11-14 | $85.28M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $27.08M 10-Q · filed 2011-08-12 | $52.41M 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $75.88M 10-K · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |